D. Waters

发表

D. Waters, 2001, Clinical cardiology.

Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys

D. Waters, 2021, CJC open.

The association between lipid levels and leukocyte count: A cross-sectional and longitudinal analysis of three large cohorts

K. Rye, B. Cochran, K. Ong, 2021, American Heart Journal Plus: Cardiology Research and Practice.

Structure of a primary care support system to coordinate comprehensive care for children and families infected/affected by human immunodeficiency virus in a managed care environment.

M. Chusid, P. Havens, B. Cuene, 1997, The Pediatric infectious disease journal.

Usefulness of Angina to Guide Revascularization Decisions

G. Stone, D. Waters, 2021, Circulation.

POTENTIAL EFFECTS OF ESTROGEN IN ACUTE CORONARY SYNDROMES

D. Waters, 2016 .

Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure Subgroup Analysis of the Treating to New Targets (TNT) Study Heart Failure

J. Kastelein, K. Khush, P. Deedwania, 2007 .

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

M. Pfeffer, J. McMurray, H. White, 2022, European heart journal.

Postmenopausal Hormone Therapy Is Associated With Atherosclerosis Progression in Women With Abnormal Glucose Tolerance Vascular Biology

J. Hsia, B. Howard, E. Alderman, 2004 .

Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study

J. Leppo, S. Nattel, D. Waters, 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Management of the infant born to a mother with HIV infection.

P. Havens, D. Waters, 2004, Pediatric clinics of North America.

Cardiovascular drugs that increase the risk of new-onset diabetes.

P. Barter, K. Ong, D. Waters, 2014, American heart journal.

Hemodynamic and Arrhythmogenic Effects of Cocaine in Hypertensive Individuals

N. Goldschlager, P. Hsue, Eric A. Secemsky, 2011, Journal of clinical hypertension.

On‐treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study

D. Waters, I. Holme, J. Kastelein, 2011, European journal of clinical investigation.

‘Second Generation’ Dihydropyridine Calcium Antagonists

D. Waters, D. Freedman, D. Waters, 1987, Drugs.

Electrical stimulation vs CAB

P. Varosy, D. Waters, 2002 .

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

P Théroux, D. Waters, R. Havel, 1990, Circulation.

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

M. Ezekowitz, B. Chaitman, D. Waters, 2001, JAMA.

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

D. Reboussin, C. Furberg, D. Waters, 2000, The New England journal of medicine.

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction.

D. Waters, J. Hung, L. Lacoste, 1995, Circulation.

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

D. Waters, M. Le May, B. Kimball, 1994, Circulation.

Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.

P. Barter, J. Kastelein, J. Tardif, 2011, Circulation.

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

R. Diaz, J. López-Sendón, J. Tardif, 2019, The New England journal of medicine.

Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.

D. Waters, P. Théroux, F. Pérez-Villa, 1995, Circulation.

A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: the Lipid Treatment Assessment Project 2.

D. Waters, J. Jukema, J. Ferrières, 2009, Atherosclerosis.

Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes.

J. Kastelein, D. Waters, J. Kastelein, 2012, Journal of the American College of Cardiology.

Lipid Treatment Assessment Project 2: A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals

K. Seung, D. Waters, J. Jukema, 2009, Circulation.

Multiple coronary angioplasty: a model to discriminate systemic and procedural factors related to restenosis.

D. Waters, J. Lespérance, M. Lambert, 1988, Journal of the American College of Cardiology.

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease

D. Sparks, H. Feldman, M. Kivipelto, 2010, Neurology.

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

P. Barter, D. Waters, J. Kastelein, 2018, Circulation.

The 719Arg Variant of KIF6 and Cardiovascular Outcomes in Statin-Treated, Stable Coronary Patients of the Treating to New Targets and Incremental Decrease in End Points Through Aggressive Lipid-Lowering Prospective Studies

P. Barter, J. Kastelein, D. Waters, 2012, Circulation. Cardiovascular genetics.

Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

R. Diaz, J. Tardif, W. Koenig, 2020 .

Plasma Lipoproteins and Progression of Coronary Artery Disease Evaluated by Angiography and Clinical Events

D. Waters, R. Havel, N. Phillips, 1993, Circulation.

Factors influencing the long-term prognosis of treated patients with variant angina.

D. Waters, D. Miller, P. Théroux, 1983, Circulation.

Regression of Coronary Atherosclerosis

D. Waters, J. Lespérance, J. Lésperance, 2012, Drugs.

Hemodynamic and Arrhythmogenic Effects of Cocaine in Hypertensive Individuals

E. Secemsky, N. Goldschlager, P. Hsue, 2011, Journal of clinical hypertension.

Calcium channel blockers: an evidence-based review.

D. Waters, D. Waters, 1997, The Canadian journal of cardiology.

A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial).

P. Stone, D. Waters, A. Wu, 2000, European heart journal.